PQ 443
443. Deputy Peter 'Chap' Cleere asked the Minister for Health the reason evorel 50mg and estradot mg are not currently covered on GMS scheme which results in patient has to pay privately for this; and if she will make a statement on the matter. [23064/25]
Introduced
8 May 2025
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
8 May 2025
Summary
443. Deputy Peter 'Chap' Cleere asked the Minister for Health the reason evorel 50mg and estradot mg are not currently covered on GMS scheme which results in patient has to pay privately for this; and if she will make a statement on the matter. [23064/25]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 8 May 2025
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2025-05-08/443/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2025-05-08/pq_443